Explore
Validate
Learn
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- H00116844-M01 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#H00116844-M01, RRID:AB_622340
- Product name
- LRG1 monoclonal antibody (M01), clone 2E3
- Antibody type
- Monoclonal
- Description
- Mouse monoclonal antibody raised against a full length recombinant LRG1.
- Antigen sequence
TLSPKDCQVFRPDHGSSISCQPPAEIPGYLPADTV
HLAVEFFNLTHLPANLLQGASKLQELHLSSNGLES
LSPEFLRPVPQLRVLDLTRNALTGLPSGLFQASAT
LDTLVLKENQLEVLEVSWLHGLKALGHLDLSGNRL
RKLPPGLLANFTLLRTLDLGENQLETLPPDLLRGP
LQLERLHLEGNKLQVLGKDLLLPQPDLRYLFLNGN
KLARVAAGAFQGLRQLDMLDLSNNSLASVPEGLWA
SLGQPNWDMRDGFDISGNPWICDQNLSDLYRWLQA
QRDKMFSQNDTRCAGPEAVKGQTLLAVAKSQ- Isotype
- IgG
- Antibody clone number
- 2E3
- Storage
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Submitted references Proteomic profiling for the identification of serum diagnostic biomarkers for abdominal and thoracic aortic aneurysms.
MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway.
Satoh K, Maniwa T, Oda T, Matsumoto K
Proteome science 2013 Jun 27;11(1):27
Proteome science 2013 Jun 27;11(1):27
MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway.
Lynch J, Fay J, Meehan M, Bryan K, Watters KM, Murphy DM, Stallings RL
Carcinogenesis 2012 May;33(5):976-85
Carcinogenesis 2012 May;33(5):976-85
No comments: Submit comment
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Detection limit for recombinant GST tagged LRG1 is approximately 0.3ng/ml as a capture antibody.
- Validation comment
- Sandwich ELISA (Recombinant protein)
- Protocol
- Protocol
